Pharmacogenomic testing-based precision medicine in the elderly: Current status and prospects / 中华老年医学杂志
Chinese Journal of Geriatrics
;
(12): 1126-1129, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-957351
ABSTRACT
Comorbidities will inevitably lead to an increase in the number of medications used and adverse drug reaction events in elderly patients.Therefore, it is urgent to implement precision medicine in the elderly population.pharmacogenomic testing can increase the opportunity of individualized drug selection for elderly patients, reduce the risk of adverse drug reactions, reduce the cost-effectiveness ratio of medication, improve elderly patients' medication compliance, and thus reduce their readmission rate.Therefore, it is necessary to promote pharmacogenetic testing for elderly patients with comorbidities and polypharmacy, so as to provide measures for the implementation of personalized medicine in the elderly.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Geriatrics
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS